CURRENT STUDIES:
Lundbeck MSA (MASCOT): Interventional, randomized, double-blind, placebo-controlled, optional open-label extension trial of Lu AF82422 in participants with Multiple System Atrophy
Takeda MSA: A Randomized, Double-blind, Placebo-Controlled, Phase 2 Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intravenous TAK-341 in Subjects With Multiple System Atrophy
Teva Branded Pharmaceutical: “A Multi-centered, Double-blind, Randomized, Placebo-controlled, Parallel Group Phase 2 Study of TEV-56286 for the Treatment of Patients with Multiple System Atrophy” TV56286-NDG-20039
What Is Multiple System Atrophy (MSA)?
MSA is a very rare disease of the nervous system, that causes damage, over time, to the brain and nerve cells. This gradual damage often affects movement, balance, and basic nervous system functions, like, digestion, breath and bladder control.